Personalised predictive modelling with brain-inspired spiking neural networks of longitudinal MRI neuroimaging data and the case study of dementia

A machine learning-based predictive model for the in-hospital mortality of critically ill patients with atrial fibrillation

BACKGROUND

Atrial fibrillation (AF) is common among intensive care unit (ICU) patients and significantly raises the in-hospital mortality rate. Existing scoring systems or models have limited predictive capabilities for AF patients in ICU. Our study developed and validated machine learning models to predict the risk of in-hospital mortality in ICU patients with AF.

METHODS AND RESULTS

Medical Information Mart for Intensive Care (MIMIC)-IV dataset and eICU Collaborative Research Database (eICU-CRD) were analyzed. Among ten classifiers compared, adaptive boosting (AdaBoost) showed better performance in predicting all-cause mortality in AF patients. A compact model with 15 features was developed and validated. Both the all variable and compact models exhibited excellent performance with area under the receiver operating characteristic curves (AUCs) of 1(95%confidence interval [CI]: 1.0-1.0) in the training set. In the MIMIC-IV testing set, the AUCs of the all variable and compact models were 0.978 (95% CI: 0.973-0.982) and 0.977 (95% CI: 0.972-0.982), respectively. In the external validation set, the AUCs of all variable and compact models were 0.825 (95% CI: 0.815-0.834) and 0.807 (95% CI: 0.796-0.817), respectively.

CONCLUSION

An AdaBoost-based predictive model was subjected to internal and external validation, highlighting its strong predictive capacity for assessing the risk of in-hospital mortality in ICU patients with AF.

Machine learning predictive models for grading bronchopulmonary dysplasia: umbilical cord blood IL-6 as a biomarker

Objectives

This study aimed to analyze the predictive value of umbilical cord blood Interleukin-6 (UCB IL-6) for the severity-graded BPD and to establish machine learning (ML) predictive models in a Chinese population based on the 2019 NRN evidence-based guidelines.

Methods

In this retrospective analysis, we included infants born with gestational age <32 weeks, who underwent UCB IL-6 testing within 24 h of admission to our NICU between 2020 and 2022. We collected their medical information encompassing the maternal, perinatal, and early neonatal phases. Furthermore, we classified the grade of BPD according to the 2019 NRN evidence-based guidelines. The correlation between UCB IL-6 and the grades of BPD was analyzed. Univariate analysis and ordinal logistic regression were employed to identify risk factors, followed by the development of ML predictive models based on XGBoost, CatBoost, LightGBM, and Random Forest. The AUROC was used to evaluate the diagnostic value of each model. Besides, we generated feature importance distribution plots based on SHAP values to emphasize the significance of UCB IL-6 in the models.

Results

The study ultimately enrolled 414 preterm infants, with No BPD group (n = 309), Grade 1 BPD group (n = 73), and Grade 2-3 BPD group (n = 32). The levels of UCB IL-6 increased with the grades of BPD. UCB IL-6 demonstrated clinical significance in predicting various grades of BPD, particularly in distinguishing Grade 2-3 BPD patients, with an AUROC of 0.815 (95% CI: 0.753-0.877). All four ML models, XGBoost, CatBoost, LightGBM, and Random Forest, exhibited Micro-average AUROC values of 0.841, 0.870, 0.851, and 0.878, respectively. Notably, UCB IL-6 consistently appeared as the most prominent feature across the feature importance distribution plots in all four models.

Conclusion

UCB IL-6 significantly contributes to predicting severity-graded BPD, especially in grade 2-3 BPD. Through the development of four ML predictive models, we highlighted UCB IL-6's importance.

Brain-Inspired Spatio-Temporal Associative Memories for Neuroimaging Data Classification: EEG and fMRI

Humans learn from a lot of information sources to make decisions. Once this information is learned in the brain, spatio-temporal associations are made, connecting all these sources (variables) in space and time represented as brain connectivity. In reality, to make a decision, we usually have only part of the information, either as a limited number of variables, limited time to make the decision, or both. The brain functions as a spatio-temporal associative memory. Inspired by the ability of the human brain, a brain-inspired spatio-temporal associative memory was proposed earlier that utilized the NeuCube brain-inspired spiking neural network framework. Here we applied the STAM framework to develop STAM for neuroimaging data, on the cases of EEG and fMRI, resulting in STAM-EEG and STAM-fMRI. This paper showed that once a NeuCube STAM classification model was trained on a complete spatio-temporal EEG or fMRI data, it could be recalled using only part of the time series, or/and only part of the used variables. We evaluated both temporal and spatial association and generalization accuracy accordingly. This was a pilot study that opens the field for the development of classification systems on other neuroimaging data, such as longitudinal MRI data, trained on complete data but recalled on partial data. Future research includes STAM that will work on data, collected across different settings, in different labs and clinics, that may vary in terms of the variables and time of data collection, along with other parameters. The proposed STAM will be further investigated for early diagnosis and prognosis of brain conditions and for diagnostic/prognostic marker discovery.

Artificial intelligence in psychiatry research, diagnosis, and therapy

Psychiatric disorders are now responsible for the largest proportion of the global burden of disease, and even more challenges have been seen during the COVID-19 pandemic. Artificial intelligence (AI) is commonly used to facilitate the early detection of disease, understand disease progression, and discover new treatments in the fields of both physical and mental health. The present review provides a broad overview of AI methodology and its applications in data acquisition and processing, feature extraction and characterization, psychiatric disorder classification, potential biomarker detection, real-time monitoring, and interventions in psychiatric disorders. We also comprehensively summarize AI applications with regard to the early warning, diagnosis, prognosis, and treatment of specific psychiatric disorders, including depression, schizophrenia, autism spectrum disorder, attention-deficit/hyperactivity disorder, addiction, sleep disorders, and Alzheimer's disease. The advantages and disadvantages of AI in psychiatry are clarified. We foresee a new wave of research opportunities to facilitate and improve AI technology and its long-term implications in psychiatry during and after the COVID-19 era.

Machine Learning for Brain MRI Data Harmonisation: A Systematic Review

BACKGROUND

Magnetic Resonance Imaging (MRI) data collected from multiple centres can be heterogeneous due to factors such as the scanner used and the site location. To reduce this heterogeneity, the data needs to be harmonised. In recent years, machine learning (ML) has been used to solve different types of problems related to MRI data, showing great promise.

OBJECTIVE

This study explores how well various ML algorithms perform in harmonising MRI data, both implicitly and explicitly, by summarising the findings in relevant peer-reviewed articles. Furthermore, it provides guidelines for the use of current methods and identifies potential future research directions.

METHOD

This review covers articles published through PubMed, Web of Science, and IEEE databases through June 2022. Data from studies were analysed based on the criteria of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Quality assessment questions were derived to assess the quality of the included publications.

RESULTS

a total of 41 articles published between 2015 and 2022 were identified and analysed. In the review, MRI data has been found to be harmonised either in an implicit (n = 21) or an explicit (n = 20) way. Three MRI modalities were identified: structural MRI (n = 28), diffusion MRI (n = 7) and functional MRI (n = 6).

CONCLUSION

Various ML techniques have been employed to harmonise different types of MRI data. There is currently a lack of consistent evaluation methods and metrics used across studies, and it is recommended that the issue be addressed in future studies. Harmonisation of MRI data using ML shows promises in improving performance for ML downstream tasks, while caution should be exercised when using ML-harmonised data for direct interpretation.

Investigation of social and cognitive predictors in non-transition ultra-high-risk' individuals for psychosis using spiking neural networks

Finding predictors of social and cognitive impairment in non-transition Ultra-High-Risk individuals (UHR) is critical in prognosis and planning of potential personalised intervention strategies. Social and cognitive functioning observed in youth at UHR for psychosis may be protective against transition to clinically relevant illness. The current study used a computational method known as Spiking Neural Network (SNN) to identify the cognitive and social predictors of transitioning outcome. Participants (90 UHR, 81 Healthy Control (HC)) completed batteries of neuropsychological tests in the domains of verbal memory, working memory, processing speed, attention, executive function along with social skills-based performance at baseline and 4 × 6-month follow-up intervals. The UHR status was recorded as Remitters, Converters or Maintained. SNN were used to model interactions between variables across groups over time and classify UHR status. The performance of SNN was examined relative to other machine learning methods. Higher interaction between social and cognitive variables was seen for the Maintained, than Remitter subgroup. Findings identified the most important cognitive and social variables (particularly verbal memory, processing speed, attention, affect and interpersonal social functioning) that showed discriminative patterns in the SNN models of HC vs UHR subgroups, with accuracies up to 80%; outperforming other machine learning models (56-64% based on 18 months data). This finding is indicative of a promising direction for early detection of social and cognitive impairment in UHR individuals that may not anticipate transition to psychosis and implicate early initiated interventions to stem the impact of clinical symptoms of psychosis.

Prediction of Tinnitus Treatment Outcomes Based on EEG Sensors and TFI Score Using Deep Learning

Tinnitus is a hearing disorder that is characterized by the perception of sounds in the absence of an external source. Currently, there is no pharmaceutical cure for tinnitus, however, multiple therapies and interventions have been developed that improve or control associated distress and anxiety. We propose a new Artificial Intelligence (AI) algorithm as a digital prognostic health system that models electroencephalographic (EEG) data in order to predict patients' responses to tinnitus therapies. The EEG data was collected from patients prior to treatment and 3-months following a sound-based therapy. Feature selection techniques were utilised to identify predictive EEG variables with the best accuracy. The patients' EEG features from both the frequency and functional connectivity domains were entered as inputs that carry knowledge extracted from EEG into AI algorithms for training and predicting therapy outcomes. The AI models differentiated the patients' outcomes into either therapy responder or non-responder, as defined by their Tinnitus Functional Index (TFI) scores, with accuracies ranging from 98%-100%. Our findings demonstrate the potential use of AI, including deep learning, for predicting therapy outcomes in tinnitus. The research suggests an optimal configuration of the EEG sensors that are involved in measuring brain functional changes in response to tinnitus treatments. It identified which EEG electrodes are the most informative sensors and how the EEG frequency and functional connectivity can better classify patients into the responder and non-responder groups. This has potential for real-time monitoring of patient therapy outcomes at home.

Optimizing the Neural Structure and Hyperparameters of Liquid State Machines Based on Evolutionary Membrane Algorithm

As one of the important artificial intelligence fields, brain-like computing attempts to give machines a higher intelligence level by studying and simulating the cognitive principles of the human brain. A spiking neural network (SNN) is one of the research directions of brain-like computing, characterized by better biogenesis and stronger computing power than the traditional neural network. A liquid state machine (LSM) is a neural computing model with a recurrent network structure based on SNN. In this paper, a learning algorithm based on an evolutionary membrane algorithm is proposed to optimize the neural structure and hyperparameters of an LSM. First, the object of the proposed algorithm is designed according to the neural structure and hyperparameters of the LSM. Second, the reaction rules of the proposed algorithm are employed to discover the best neural structure and hyperparameters of the LSM. Third, the membrane structure is that the skin membrane contains several elementary membranes to speed up the search of the proposed algorithm. In the simulation experiment, effectiveness verification is carried out on the MNIST and KTH datasets. In terms of the MNIST datasets, the best test results of the proposed algorithm with 500, 1000 and 2000 spiking neurons are 86.8%, 90.6% and 90.8%, respectively. The best test results of the proposed algorithm on KTH with 500, 1000 and 2000 spiking neurons are 82.9%, 85.3% and 86.3%, respectively. The simulation results show that the proposed algorithm has a more competitive advantage than other experimental algorithms.

Machine learning, artificial intelligence and the prediction of dementia

PURPOSE OF REVIEW

Artificial intelligence and its division machine learning are emerging technologies that are increasingly applied in medicine. Artificial intelligence facilitates automatization of analytical modelling and contributes to prediction, diagnostics and treatment of diseases. This article presents an overview of the application of artificial intelligence in dementia research.

RECENT FINDINGS

Machine learning and its branch Deep Learning are widely used in research to support in diagnosis and prediction of dementia. Deep Learning models in certain tasks often result in better accuracy of detection and prediction of dementia than traditional machine learning methods, but they are more costly in terms of run times and hardware requirements. Both machine learning and Deep Learning models have their own strengths and limitations. Currently, there are few datasets with limited data available to train machine learning models. There are very few commercial applications of machine learning in medical practice to date, mostly represented by mobile applications, which include questionnaires and psychometric assessments with limited machine learning data processing.

SUMMARY

Application of machine learning technologies in detection and prediction of dementia may provide an advantage to psychiatry and neurology by promoting a better understanding of the nature of the disease and more accurate evidence-based processes that are reproducible and standardized.